Sequent Scientific P/E Ratio

SEQUENT • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
165.81
High Valuation
Very High - High growth expectations or significantly overvalued

Current Valuation Metrics

P/E Ratio 165.81
Current Price ₹193.98
EPS (TTM) ₹0.88
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 43.72
Historical Range 18.04 - 79.05
Percentile 100.0%

Sector Context

Sector Average 46.64
Sector Median 25.5
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹1.64
Sept 2025 ₹0.59
Mar 2025 ₹0.37

Key P/E Ratio Insights for Sequent Scientific

  • Stock appears overvalued with PE of 165.81, suggesting caution for new investments
  • Current PE is 279.2% above historical average
  • Trading at premium to sector average PE of 46.64

P/E Ratio Historical Trend for Sequent Scientific

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2021 79.05 2.15 ₹169.95 NSE High
2020 18.04 3.93 ₹70.90 NSE Moderate
2019 23.49 2.89 ₹67.90 NSE Moderate
2018 54.31 1.45 ₹78.75 NSE High

Sector P/E Ratio Comparison

Comparing Sequent Scientific with other companies in Healthcare sector
Sector Average
46.64
Sector Median
25.5
Lowest P/E
0.83
Highest P/E
898.7
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.83 ₹31 Low
Murae Organisor MURAE 2.86 ₹41 Low
Ind Swift Laboratories INDSWFTLAB 4.53 ₹1,133 Low
Amwill Health Care AMWILL 5.67 ₹64 Low
Brooks Laboratories BROOKS 6.14 ₹157 Low
Medicamen Organics MEDIORG 6.4 ₹27 Low
Zenith Drugs ZENITHDRUG 6.83 ₹69 Low
Unichem Laboratories UNICHEMLAB 7.15 ₹2,100 Low
Galaxy Medicare GML 7.41 ₹26 Low
Vasundhara Rasayans VRL 9.35 ₹34 Low